Hemoglobin induces the production and release of matrix metalloproteinase-9 from human malignant cells

Blood Coagulation and Fibrinolysis

Volumn 14, Issue 5, 2003, Pages 449-455

  Siddiqui, Farooq A ^a   Siddiqui, Tazeen F ^a   Francis, John L ^a  

^a FLORIDA HOSPITAL CANCER INSTITUTE   (United States)

Author keywords

Hemoglobin; MMP 9; Tumor cells

Indexed keywords

CYCLOHEXIMIDE; GELATINASE B; GENISTEIN; HEMOGLOBIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; THROMBOPLASTIN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BLADDER CANCER; CANCER CELL; CONTROLLED STUDY; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; MELANOMA; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; ZYMOGRAPHY;

CARCINOMA; CYCLOHEXIMIDE; ENZYME INHIBITORS; FLAVONOIDS; GENISTEIN; HEMOGLOBINS; HUMANS; LEUKEMIA, MYELOID; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 9; MELANOMA; NEOPLASM PROTEINS; PROTEIN SYNTHESIS INHIBITORS; PROTEIN-TYROSINE KINASES; TUMOR CELLS, CULTURED; TUMOR STEM CELLS; URINARY BLADDER NEOPLASMS;

EID: 0041624408     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200307000-00004     Document Type: Article

References (37)

1. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI. SV40-transformed human lung fibroblasts secrete a 92-KDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 1989; 264:17213-17221.
2. Olson MW, Bernardo MM, Pietila M, Gervasi DC, Toth M, Kotra LP, et al. Characterization of the monomeric and dimeric forms of latent and active matrix metalloproteinase-9. J Biol Chem 2000; 275:2661-2668.
3. Nielson BS, Timsel S, Kjeldsen L, Sehested M, Pyke C, Borregaard N, Dano K. 92 KDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer. Int J Cancer 1996; 65:57-62.
4. Okada A, Belloeq JP, Rouyer N, Chenard MP, Rio MC, Chambon P, Basset P. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast and head and neck carcinoma. Proc Natl Acad Sci USA 1995; 92:2730-2744.
5. Baramova EN, Bajou K, L'Hoir C, Krell HW, Weidle UN, Noel A, Foidart JM. Involvement of PA/plasmin system in the processing of pro-MMP-9 and in the second step of pro-MMP-2 activation. FEBS Lett 1997; 405:157-162.
6. Vissers MC, Winterbourn CC. Activation of human neutrophil gelatinase by endogenous serine proteases. Biochem J 1966; 249:327-331.
7. Desrivieres S, Lu H, Soria S, Legrand Y, Menashi S. Activation of 92 KDa Type IV collagenase by tissue kallikrein. J Cell Physiol 1993; 157:587-593.
8. Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 2000; 1477:267-283.
9. Dollery CM, McEwan JR, Henney AM. Matrix metalloproteinases and cardiovascular diseases. Circ Res 1995; 77:863-868.
10. Ohno I, Ohtani H, Nitta Y, Suzuki J, Hoshi H, Honma M, et al. Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. Am J Respir Cell Mol Biol 1997; 16:212-219.
11. Moses MA, Marikovsky M, Harper JW, Vogt P, Eriksson E, Klagsburn M, Langer R. Temporal study of the activity of matrix metalloproteinases and their endogenous inhibitors during wound healing. J Cell Biochem 1996; 60:379-386.
12. Ray JM, Stetler-Stevenson WG. The role of matrix metalloproteinases and their inhibitors in tumor invasion, metastasis and angiogenesis. Eur Respir J 1994; 7:2062-2072.
13. Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997; 89: 1260-1270.
14. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki H, et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000; 2:737-744.
15. Pepper MS. Role of matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arteioscler Thromb Vasc Biol 2001; 21:1104-1117.
16. Thomas KA. Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem 1996; 71:603-606.
17. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992; 13:18-32.
18. Clauss M, Weich H, Breier G, Knies URW, Waltenberger J, Risan W. The vascular endothelial growth factor receptor Flt-1 mediates biological activity. Implications for a functional role of placental growth factor in monocyte activation and chemotaxis. J Biol Chem 1996; 271:17629-17634.
19. Wang He, Keiser JA. Vascular endothelial growth factor up-regulates the expression of matrix metalloproteinases in vascular smooth muscle cells. Circ Res 1998; 83:832-840.
20. Zucker S, Mirza H, Conner CE, Lorenz AF, Drews MH, Bahou WF, Jesty J. Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation. Int J Cancer 1998; 75:780-786.
21. Siddiqui FA, Amirkhosravi A, Amaya M, Meyer T, Biggerstaff J, Desai H, Francis JL. Hemoglobin enhances tissue factor expression on human malignant cells. Blood Coagul Fibrinolysis 2001; 12:171-177.
22. Siddiqui FA, Desai H, Siddiqui TS, Francis JL. Hemoglobin induces the expression and secretion of vascular endothelial growth factor from human malignant cells. Hematol J 2002; 3:264-270.
23. Siddiqui FA, Francis JL. Hemoglobin binds melanoma cell tissue factor and enhances its procoagulant activity. Blood Coagul Fibrinolysis 2002; 13:173-180.
24. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principal of protein dye binding. Anal Biochem 1976; 72:248-254.
25. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacterophase T4. Nature (London) 1970; 227:680-685.
26. Siddiqui FA, Amirkhosravi A, Amaya M, Desai H, Meyer T, Francis JL. Purification and properties of human malignant cell tissue factor. Clin Appl Thromb Haemost 2001, 7:289-295.
27. Siddiqui FA, Desai H, Amirkhosravi A, Amaya M, Francis JL. The presence and release of tissue factor from human platelets. Platelets 2002; 13:247-253.
28. Denkert C, Siegert A, Leclere A, Turzynski A, Hauptmann S. An inhibitor of stress-activated MAP-kinases reduces invasion and MMP-2 expression of malignant melanoma cells. Clin Exp Metastasis 2002, 19:79-85.
29. Zhang Y, Deng Y, Luther T, Muller M, Ziegler R, Waldherr R, et al. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest 1994, 94:1320-1327.
30. Abdulkadir SA, Carvalhal GF, Kaleem Z, Kisiel W, Humphrey PA, Catalona WJ, Milbrandt J. Tissue factor expression and angiogenesis in human prostate carcinoma. Hum Pathol 2000, 31:443-447.
31. Mueller BM, Reisfield RA, Edgington TS, Ruf W. Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc Natl Acad Sci USA 1992, 89:11832-11836.
32. Bromberg ME, Sundaram R, Homer RJ, Garen A, Konigberg WH. Role of tissue factor in metastasis: functions of the cytoplasmic and extracellular domains of the molecule. Thromb Haemost 1999, 82:88-92.
33. Morrissey JH, Revak D, Tejada P, Fairs D, Edgington TS. Resolution of monomeric and heterodimeric forms of tissue factor, the high affinity cellular receptor for FVII. Thromb Res 1988; 50:481-493.
34. Roth RI. Hemoglobin enhances the production of tissue factor by endothelial cells in response to bacterial endotoxin. Blood 1994; 83:2860-2865.
35. Abe K, Shoji M, Chen J, Bierhaus A, Danave I, Micko C, et al. Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. Proc Natl Acad Sci USA 1999, 96:8663-8668.
36. Baker JE, Wandersee NJ. Thrombosis in heritable hemolytic disorders. Curr Opin Hematol 1999, 6:71-75.
37. Katoh M, Shigematsu H. Renal involvement of thrombotic thrombocytopenic purpura: special reference to the glomeruloid structures. Pathol Int 1999; 49:638-642.